Market Overview

Benzinga's Top Upgrades, Downgrades For February 16, 2018

Share:

Top Upgrades

  • Analysts at Guggenheim upgraded Wendys Co (NASDAQ: WEN) from Neutral to Buy. Wendy's shares fell 0.32 percent to close at $15.70 on Wednesday.
  • BMO Capital upgraded Omnicom Group Inc. (NYSE: OMC) from Market Perform to Outperform. Omnicom Group shares fell 6.64 percent to close at $77.28 on Thursday.
  • Imperial Capital upgraded AlarmCom Hldg Inc (NASDAQ: ALRM) from In-Line to Outperform. Alarm.com shares rose 2.46 percent to close at $37.88 on Thursday.
  • Stifel Nicolaus upgraded Allison Transmission Holdings Inc (NYSE: ALSN) from Hold to Buy. Allison Transmission shares dropped 4.38 percent to close at $40.38 on Thursday.
  • Wells Fargo upgraded Trinity Industries Inc (NYSE: TRN) from Market Perform to Outperform. Trinity Industries shares rose 1.29 percent to $34.50 in pre-market trading.
  • Macquarie upgraded Interpublic Group of Companies Inc (NYSE: IPG) from Underperform to Neutral. Interpublic shares rose 2.37 percent to close at $25.06 on Thursday.
  • Analysts at DA Davidson upgraded NetApp Inc. (NASDAQ: NTAP) from Neutral to Buy. NetApp shares slipped 0.47 percent to $57.40 in pre-market trading.
  • Analysts at BMO Capital upgraded Sun Life Financial Inc (NYSE: SLF) from Market Perform to Outperform. Sun Life Financial shares gained 2.88 percent to close at $42.52 on Thursday.
  • Credit Suisse upgraded Huntington Ingalls Industries Inc (NYSE: HII) from Neutral to Outperform. Huntington Ingalls shares rose 1.02 percent to $258.00 in pre-market trading.


Top Downgrades

  • Analysts at Jefferies downgraded Dr Pepper Snapple Group Inc. (NYSE: DPS) from Buy to Hold. Dr Pepper Snapple rose 0.50 percent to close at $115.51 on Thursday.
  • Barclays downgraded Sapiens International Corporation N.V. (NASDAQ: SPNS) from Overweight to Equal-Weight. Sapiens shares fell 1.25 percent to $9.45 in pre-market trading.
  • Longbow Research downgraded A Schulman Inc (NASDAQ: SHLM) from Buy to Neutral. A. Schulman shares climbed 10.61 percent to close at $42.75 on Thursday.
  • Wells Fargo downgraded Ares Management LP (NYSE: ARES) from Outperform to Market Perform. Ares Management shares rose 7.71 percent to close at $24.45 on Thursday.
  • Canaccord Genuity downgraded Amber Road Inc (NYSE: AMBR) from Buy to Hold. Amber Road shares fell 2.06 percent to close at $9.74 on Thursday.
  • Cowen & Co. downgraded PBF Energy Inc (NYSE: PBF) from Outperform to Market Perform. PBF Energy shares slipped 0.03 percent to close at $30.19 on Thursday.
  • RBC Capital downgraded Omnicom Group Inc. (NYSE: OMC) from Outperform to Sector Perform. Omnicom shares fell 6.64 percent to close at $77.28 on Thursday.
  • Argus downgraded Biogen Inc (NASDAQ: BIIB) from Buy to Hold. Biogen shares gained 1.11 percent to close at $299.38 on Thursday.
  • CL King downgraded Bio-Rad Laboratories, Inc. (NYSE: BIO) from Buy to Neutral. Bio-Rad Laboratories shares slipped 0.45 percent to close at $246.83 on Thursday.


Top Initiations

  • Analysts at Benchmark initiated coverage on One Stop Systems Inc (NASDAQ: OSS) with a Buy rating. The price target for One Stop Systems is set to $8. One Stop Systems shares closed at $4.76 on Thursday.
  • H.C. Wainwright assumed coverage on Aerie Pharmaceuticals Inc (NASDAQ: AERI with a Buy rating. The price target for Aerie Pharmaceuticals is set to $78. Aerie Pharmaceuticals shares closed at $53.65 on Thursday.
  • Stifel Nicolaus initiated coverage on H&E Equipment Services, Inc. (NASDAQ: HEES) with a Buy rating. The price target for H&E Equipment is set to $46. H&E Equipment shares closed at $36.08 on Thursday.
  • RBC Capital initiated coverage on Centennial Resource Development Inc (NASDAQ: CDEV) with an Outperform rating. The price target for Centennial Resource Development is set to $26. Centennial Resource Development shares closed at $18.76 on Thursday.
  • Analysts at B. Riley initiated coverage on Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) with a Buy rating. The price target for Deciphera Pharmaceuticals is set to $43. Deciphera Pharmaceuticals shares closed at $28.70 on Thursday.
  • Buckingham initiated coverage on At Home Group Inc. (NYSE: HOME) with a Buy rating. The price target for At Home is set to $43. At Home shares closed at $30.12 on Thursday.

Posted-In: Initiations top upgradesUpgrades Downgrades Initiation Pre-Market Outlook Analyst Ratings

 

Related Articles (ALSN + ALRM)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
PEPMorgan StanleyReiterates137.0
AZRXH.C. WainwrightMaintains7.0
PEPMacquarieMaintains138.0
POLBuckinghamMaintains36.0
BKBuckinghamMaintains53.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Where Is The Floor For The USD/JPY?

Alarm.com: 4 Reasons Why Imperial Capital Turned Bullish